OppenheimerFunds, Inc. - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 264 filers reported holding MYRIAD GENETICS INC in Q1 2019. The put-call ratio across all filers is 2.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
OppenheimerFunds, Inc. ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q1 2019$493,000
+32.2%
14,859
+15.9%
0.00%0.0%
Q4 2018$373,000
-24.3%
12,825
+19.6%
0.00%0.0%
Q3 2018$493,000
+7.2%
10,725
-12.8%
0.00%0.0%
Q2 2018$460,000
-5.7%
12,304
-25.4%
0.00%0.0%
Q1 2018$488,000
-13.5%
16,498
+0.4%
0.00%0.0%
Q4 2017$564,000
-8.4%
16,438
-3.5%
0.00%0.0%
Q3 2017$616,000
-5.4%
17,042
-32.3%
0.00%0.0%
Q2 2017$651,000
+12.4%
25,175
-16.6%
0.00%0.0%
Q1 2017$579,00030,1710.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 6,459,139$278,776,0005.53%
Tieton Capital Management, LLC 119,290$5,149,0004.04%
RPg Family Wealth Advisory, LLC 97,202$4,195,238,0003.85%
RK Capital 384,900$16,612,0002.90%
Contrarius Investment Management Ltd 652,288$28,153,0002.65%
S&T BANK/PA 331,885$14,324,0002.22%
Euclidean Technologies Management, LLC 40,917$1,766,0001.90%
AIMZ Investment Advisors, LLC 45,635$1,970,0001.80%
Taylor Frigon Capital Management LLC 34,783$1,486,0001.67%
KILLEN GROUP INC 366,305$15,810,0001.63%
View complete list of MYRIAD GENETICS INC shareholders